TAMMY WEBB: Open Payments
NPI 1720196074 · PAINTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 43 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $366 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $62 |
| Madrigal Pharmaceuticals | 3 | $51 |
| Alkermes, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: HETLIOZ, CAPLYTA, FANAPT, TRINTELLIX, REXULTI, REZDIFFRA, ARISTADA, Auvelity.
Industry payments across KY — which companies pay providers there.
